Drug Shortage Report for LUPIN-CEPHALEXIN

Last updated on 2023-04-06 History
Report ID 181400
Drug Identification Number 02469189
Brand name LUPIN-CEPHALEXIN
Common or Proper name LUPIN-CEPHALEXIN
Company Name LUPIN PHARMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CEPHALEXIN
Strength(s) 250MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 100 ML
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-01-18
Estimated end date 2023-04-04
Actual end date 2023-04-05
Shortage status Resolved
Updated date 2023-04-06
Company comments Resolved
Health Canada comments
Tier 3 Status No
Contact Address 550-1111 RUE ST-CHARLES OUEST
LONGUEUIL, QUEBEC
CANADA J4K 5G4
Company contact information lupin@lsu3pl.ca (Customer service / Service à la clientèle)

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2023-04-06 English Compare
v13 2023-04-05 French Compare
v12 2023-04-05 English Compare
v11 2023-04-05 French Compare
v10 2023-04-05 English Compare
v9 2023-04-05 English Compare
v8 2023-01-19 English Compare
v7 2023-01-18 French Compare
v6 2023-01-18 English Compare
v5 2023-01-18 French Compare
v4 2023-01-18 English Compare
v3 2023-01-18 English Compare
v2 2023-01-18 French Compare
v1 2023-01-18 English Compare

Showing 1 to 14 of 14